HPV serostatus pre- and post-vaccination in a randomized phase II preparedness trial among young Western Cape, South African women: The evri trial

BACKGROUND: HPV antibodies are a marker of past exposure to the virus. Our objective was to assess HPV serostatus pre- and post-vaccination among HIV-negative women. METHODS: Women aged 16–24 years old were randomized in a placebo controlled trial utilizing the 4-valent HPV (4vHPV) vaccine (NCT01489...

Descripción completa

Detalles Bibliográficos
Autores principales: Sudenga, Staci L., Torres, B. Nelson, Botha, Matthys H., Zeier, Michele, Abrahamsen, Martha E., Glashoff, Richard H., Engelbrecht, Susan, Schim Van der Loeff, Maarten F., Van der Laan, Louvina E., Kipping, Siegfried, Taylor, Douglas, Giuliano, Anna R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417542/
https://www.ncbi.nlm.nih.gov/pubmed/28480334
http://dx.doi.org/10.1016/j.pvr.2017.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417542/
https://www.ncbi.nlm.nih.gov/pubmed/28480334
http://dx.doi.org/10.1016/j.pvr.2017.02.001

Ejemplares similares